Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix

Clinical development of the oral gonadotropin-releasing hormone antagonist elagolix

Elagolix is the first oral gonadotropin-releasing hormone antagonist that entered clinical development and received regulatory approval for the management of women with endometriosis and heavy menstrual bleeding associated with uterine fibroids in combination with a hormonal add-back therapy. This m...

Full description

Bibliographic Details
Main Author:	Kristof Chwalisz, M.D., Ph.D.
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	F&S Reports
Subjects:	Elagolix GnRH antagonist endometriosis uterine fibroids
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666334123000107

Similar Items

The role of elagolix in the suppression of ovulation in donor oocyte cycles
by: Catherine Boniface, M.D., et al.
Published: (2023-06-01)

Clinical Utility Of Elagolix As An Oral Treatment For Women With Uterine Fibroids: A Short Report On The Emerging Efficacy Data
by: Neri M, et al.
Published: (2019-10-01)

Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis
by: Juliawati Muhammad, et al.
Published: (2022-01-01)

Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
by: Michael C. Snabes, M.D., Ph.D., et al.
Published: (2023-06-01)

An Efficient UPLC-MS/MS Method Established to Detect Relugolix Concentration in Rat Plasma
by: Liying Xing, et al.
Published: (2022-06-01)

Gonadotropin-Releasing Hormone Antagonists—A New Hope in Endometriosis Treatment?
by: Anna Maria Rzewuska, et al.
Published: (2023-01-01)

Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine
by: Farrah L. Saleh, M.D., et al.
Published: (2023-06-01)

Gonadotropin-Releasing Hormone Receptors in Prostate Cancer: Molecular Aspects and Biological Functions
by: Fabrizio Fontana, et al.
Published: (2020-12-01)

Ultrasonographic Evaluation of the Change in Uterine Fibroids Induced by Treatment with a Gnrh Analog
by: Chun-Chieh Chia, et al.
Published: (2006-06-01)

Uterine Fibroids and Progestogen Treatment: Lack of Evidence of Its Efficacy: A Review
by: Jacques Donnez
Published: (2020-12-01)

Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration
by: Jacques Donnez, et al.
Published: (2021-12-01)

A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
by: Yoshiyuki Miyazawa, et al.
Published: (2017-08-01)

Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
by: Tayebeh Esfidani, et al.
Published: (2021-10-01)

Recent Development of Non-Peptide GnRH Antagonists
by: Feng-Ling Tukun, et al.
Published: (2017-12-01)

The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol
by: Shen Zhao, et al.
Published: (2023-01-01)

GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
by: Ensieh Tehraninejad, et al.
Published: (2011-01-01)

Editorial: Gonadotropin-Releasing Hormone Receptor Signaling and Functions
by: Ivana Bjelobaba, et al.
Published: (2018-04-01)

GnRH agonist for final oocyte maturation in GnRH antagonist co-treated IVF/ICSI treatment cycles: Systematic review and meta-analysis
by: M.A.F. Youssef, et al.
Published: (2015-05-01)

Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
by: Juan C. Arjona Ferreira, M.D., et al.
Published: (2023-06-01)

Neurobiological study of fish brains gives insights into the nature of Gonadotropin-releasing hormone 1-3 neurons.
by: Tomomi eKarigo, et al.
Published: (2013-11-01)

Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study
by: Samuele Ciceri, et al.
Published: (2023-05-01)

Comparison of the Effects of Gonadotropin Releasing Hormone Agonists and Antagonists on Endometrial Development in Women who Had Inadequate Endometrial Development in a Previous Assisted Reproduction Treatment Cycle; A Randomised Parallel Group Pilot Trial
by: Özkan Aydın Leylek, et al.
Published: (2008-12-01)

Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment: study protocol for a randomised controlled trial
by: Yun Wang, et al.
Published: (2018-08-01)

Adverse cardiovascular effect following gonadotropin-releasing hormone antagonist versus GnRH agonist for prostate cancer treatment: A systematic review and meta-analysis
by: Li Gu, et al.
Published: (2023-03-01)

Preliminary Report on the Effect of a Lower Dose of Gonadotropin-Releasing Hormone Antagonist (Cetrorelix) on Ovarian Hyperstimulation in Lower-Weight Asian Women
by: Yung-Ling Chang, et al.
Published: (2006-12-01)

Use of gonadotropin-releasing hormone (GnRH) agonist trigger in fertility preservation for patients with inherited genetic disorders
by: Jamie Merkison, et al.
Published: (2022-09-01)

GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial
by: Francesco M. Fusi, et al.
Published: (2019-11-01)

Conservative Management of Uterine Fibroid-Related Heavy Menstrual Bleeding and Infertility: Time for a Deeper Mechanistic Understanding and an Individualized Approach
by: Marie-Madeleine Dolmans, et al.
Published: (2021-09-01)

Endometriosis-Related Pain Reduction During Bleeding and Nonbleeding Days in Women Treated with Elagolix
by: Agarwal SK, et al.
Published: (2021-02-01)

Coasting Versus GnRH Antagonist Salvage for the Prevention of Ovarian Hyperstimulation Syndrome
by: Cavidan Gülerman, et al.
Published: (2016-05-01)

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome
by: Batool Hossein Rashidi, et al.
Published: (2015-10-01)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
by: Cornelis B. Lambalk, M.D., Ph.D.
Published: (2023-06-01)

Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF/ICSI: a propensity-score matching analysis
by: Liting Zhang, et al.
Published: (2022-12-01)

Systematic review and meta-analysis on the effect of adjuvant gonadotropin-releasing hormone agonist (GnRH-a) on pregnancy outcomes in women with endometriosis following conservative surgery
by: Xuemei Qing, et al.
Published: (2024-04-01)

Comparison of pregnancy outcome after fresh embryo transfer between GnRH antagonist and GnRH agonist regimens in patients with thin endometrium
by: Depeng Zhao, et al.
Published: (2023-01-01)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
by: Andrea Roberto Carosso, et al.
Published: (2021-03-01)

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial
by: Jared C. Robins, M.D., et al.
Published: (2020-12-01)

Early preclinical work with gonadotropin-releasing hormone analogues
by: Keith Gordon, Ph.D.
Published: (2023-06-01)

Micro-dose flare-up gonadotrophin-releasing hormone (GnRH) agonist vs. flexible gonadotrophin-releasing hormone (GnRH) antagonist protocol in patient with poor ovarian reserve
by: Zakia Mahdy Ibrahim, et al.
Published: (2011-12-01)

Gonadotropin releasing hormone agonists: Expanding vistas
by: Navneet Magon
Published: (2011-01-01)